• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Phosphoinositide-3-kinase-interacting protein 1 (PIK3IP1), Truncated

ACP13210

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13210 Target NamePIK3IP1
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96FE7
Background Information
  • Uniprot Id

    Q96FE7

  • Target Species

    Human

  • Target Name

    PIK3IP1

  • Target Full Name

    Phosphoinositide-3-kinase-interacting protein 1

  • Target Function

    Negative regulator of hepatic phosphatidylinositol 3-kinase (PI3K) activity.

  • Target Subcellular Location

    Cell membrane; Single-pass type I membrane protein.

  • Target Synonyms

    HGFL; hHGFL(S); Kringle domain containing protein HGFL ; Kringle domain-containing protein HGFL; MGC17330; P3IP1_HUMAN; Phosphoinositide 3 kinase interacting protein 1; Phosphoinositide-3-kinase-interacting protein 1; PIK3IP1

  • Target Background

    Enables phosphatidylinositol 3-kinase catalytic subunit binding activity. Involved in negative regulation of phosphatidylinositol 3-kinase activity and negative regulation of phosphatidylinositol 3-kinase signaling. Predicted to be located in plasma membrane. Predicted to be integral component of membrane.

Inquire Recombinant Human Phosphoinositide-3-kinase-interacting protein 1 (PIK3IP1), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification